Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
LA JOLLA PHARMACEUTICAL CO has filed 1,496 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 726-750 of 866 matching filings.

Per page
25
Current page
30
8-K File 000-24274

FORM 8-K

Filing date
16 May 2013
Reporting date
14 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

FORM 8-K

Filing date
15 May 2013
Reporting date
13 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-24274

DEF 14A

Filing date
13 May 2013
Reporting date
05 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 000-24274

PRER14A

Filing date
10 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-24274

PRE 14A

Filing date
03 May 2013
Reporting date
05 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
01 May 2013
Reporting date
29 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
01 May 2013
Reporting date
29 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

OUTSTANDING SHAREUPDATE

Filing date
29 Apr 2013
Reporting date
26 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

FORM 8-K

Filing date
04 Apr 2013
Reporting date
04 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Mar 2013
Reporting date
12 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
22 Mar 2013
Reporting date
01 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-44849

SCHEDULE 13D

Filing date
22 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44849

SC 13G/A filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44849

AMENDMENT NO. 3

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44849

SC 13G/A

Filing date
13 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

PRESS RELEASE PATENT

Filing date
05 Feb 2013
Reporting date
05 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

FORM 8-K

Filing date
04 Feb 2013
Reporting date
31 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

MONEYSHOW PRESS RELEASE

Filing date
31 Jan 2013
Reporting date
31 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

1ST PATIENT TREATED PRESS RELEASE

Filing date
28 Jan 2013
Reporting date
28 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

PRESS RELEASE

Filing date
17 Jan 2013
Reporting date
17 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24274

CHANGE OF AUDITOR

Filing date
14 Jan 2013
Reporting date
08 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .